Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Piver

Showing results (31-40 of 279) with videos related to

Pageof 28
Sort By:
Human Reproduction (Oxford, England)|February 1, 1997
Prophylactic oophorectomy: a century-long dilemmaM S Piver, C Wong
European Journal of Gynaecological Oncology|January 1, 1988
Treatment of metastatic lipid cell tumor of the ovary with BV-CAP and VAC chemotherapy, using serum testosterone and dihydrotestosterone as tumor markersB Patsner, M S Piver
Obstetrics and Gynecology|February 1, 1991
Serial CA 125 levels during chemotherapy for metastatic or recurrent endometrial cancerJ Fanning, M S Piver
Postgraduate Medicine|March 1, 1985
Clinically localized ovarian cancer. Progress in managementM S Piver, B Patsner
New York State Journal of Medicine|July 1, 1979
Childhood ovarian cancers. New advances in treatmentM S Piver, J Lurain
Seminars in Surgical Oncology|January 1, 1986
Ovarian cancer in childrenM S Piver, T Patton
Gynecologic Oncology|May 1, 1986
The potential for optimal (less than or equal to 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: a prospective studyM S Piver, T Baker
Obstetrics and Gynecology|September 1, 1976
Preoperative and intraoperative evaluation in ovarian malignancyM S Piver, J J Barlow
Oncology (Williston Park, N.Y.)|June 30, 1998
Extraovarian primary peritoneal carcinomaG H Eltabbakh, M S Piver
Gynecologic Oncology|April 1, 1979
Second-line efficacy of intermediate high-dose methotrexate with citrovorum factor rescue + cyclophosphamide in ovarian cancerJ J Barlow, M S Piver
Pageof 28

Showing results (31-40 of 279) with videos related to

Sort By:
Pageof 28
Human Reproduction (Oxford, England)|February 1, 1997
Prophylactic oophorectomy: a century-long dilemmaM S Piver, C Wong
European Journal of Gynaecological Oncology|January 1, 1988
Treatment of metastatic lipid cell tumor of the ovary with BV-CAP and VAC chemotherapy, using serum testosterone and dihydrotestosterone as tumor markersB Patsner, M S Piver
Obstetrics and Gynecology|February 1, 1991
Serial CA 125 levels during chemotherapy for metastatic or recurrent endometrial cancerJ Fanning, M S Piver
Postgraduate Medicine|March 1, 1985
Clinically localized ovarian cancer. Progress in managementM S Piver, B Patsner
New York State Journal of Medicine|July 1, 1979
Childhood ovarian cancers. New advances in treatmentM S Piver, J Lurain
Seminars in Surgical Oncology|January 1, 1986
Ovarian cancer in childrenM S Piver, T Patton
Gynecologic Oncology|May 1, 1986
The potential for optimal (less than or equal to 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: a prospective studyM S Piver, T Baker
Obstetrics and Gynecology|September 1, 1976
Preoperative and intraoperative evaluation in ovarian malignancyM S Piver, J J Barlow
Oncology (Williston Park, N.Y.)|June 30, 1998
Extraovarian primary peritoneal carcinomaG H Eltabbakh, M S Piver
Gynecologic Oncology|April 1, 1979
Second-line efficacy of intermediate high-dose methotrexate with citrovorum factor rescue + cyclophosphamide in ovarian cancerJ J Barlow, M S Piver
Pageof 28